.
MergerLinks Header Logo

Announced

Completed

The Carlyle Group and Cool Japan Fund led a $222m investment in Spiber.

Financials

Edit Data
Transaction Value£160m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Minority

orthopaedic biomaterials

Friendly

Private Equity

Japan

Cross Border

Private

biomanufacturing

Chemicals and Synthetic Fibres

Acquisition

Completed

Synopsis

Edit

The Carlyle Group and Cool Japan Fund, an investment company, led a $222m investment in Spiber, a biomanufacturing startup. Other investors include Fidelity, Baillie Gifford, Tokyo Century, Yamagata Bank and Satake Chemical Equipment. “Under the strong leadership of co- founders, Mr. Sekiyama and Mr. Sugahara, Spiber has grown from a promising Japanese start-up to the global leading player in the field of sustainable materials. At Carlyle, ESG is fully embedded into ourinvestment and value creation processes, as we seek to optimize the sustainability outcomes of each of our portfolio companies. Spiber’s mission and philosophy match Carlyle’s view to provide solutions that create long-term, sustainable value and impact as in our investments in Jeanologia and Beautycounter. We are honoured that Spiber has chosen Carlyle as its cornerstone investor," Yusuke Watanabe, Carlyle Managing Director.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US